The Sbarro Health Research Organisation (SHRO) is a nonprofit organisation dedicated to funding outstanding basic genetic research to treat and prevent cancer, heart disease, diabetes, and other chronic illnesses as well as to promote the professional and ethical training of future medical professionals. Following his discovery of the tumour suppressor gene pRb2 and the cell cycle genes CDK9 and CDK10, Antonio Giordano, M.D., Ph.D., established the Sbarro Health Research Organisation Institute in 1993 with a generous donation from Mario Sbarro, the founder of the Sbarro restaurant chain.
www.shro.org/